股本结构
单位：万股
| 公告日期 | 2021-12-14 | 2021-11-15 | 2021-11-15 | 2021-08-16 | 2021-08-16 | 2021-05-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 4162.26 | 4149.15 | 4149.20 | 4144.88 | 4145.10 | 4144.03 |
| 普通股本 | 4162.26 | 4149.15 | 4149.20 | 4144.88 | 4145.10 | 4144.03 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2021-12-14 | 2021-11-10 | 2021-09-30 | 2021-08-15 | 2021-06-30 | 2021-05-13 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2021-12-14 | 4162.26 | 未披露 | 定期报告 | 2021-12-14 |
| 2021-11-15 | 4149.15 | 未披露 | 定期报告 | 2021-11-10 |
| 2021-11-15 | 4149.20 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of Common Stock pursuant to the 2020 Equity Plan
|
2021-09-30 |
| 2021-08-16 | 4144.88 | 未披露 | 定期报告 | 2021-08-15 |
| 2021-08-16 | 4145.10 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of employee stock options
Issuance of Common Stock pursuant to the 2020 Equity Plan
|
2021-06-30 |
| 2021-05-13 | 4144.03 | 未披露 | 定期报告 | 2021-05-13 |
| 2021-04-27 | 4143.16 | 未披露 | 定期报告 | 2021-04-16 |
| 2021-05-13 | 4142.50 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Exercise of employee stock options
Issuance of Common Stock pursuant to the 2020 Equity Plan
|
2021-03-31 |
| 2021-02-26 | 4054.86 | 未披露 | 定期报告 | 2021-02-26 |
| 2021-02-26 | 4053.86 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Conversion of redeemable convertible preferred stock to common stock
Initial public offering, net of issuance costs of $11.8 million
Common stock conversion
Exercise of vested employee stock options
Exercise of stock warrants
Issuance of Common Stock pursuant to the 2020 Equity Plan
|
2020-12-31 |
| 2020-11-16 | 4053.15 | 未披露 | 定期报告 | 2020-11-13 |
| 2020-11-16 | 4042.02 | 未披露 |
更多>>
from June 30, 2020 to September 30, 2020
Exercise of employee stock options
|
2020-09-30 |
| 2020-08-11 | 4015.15 | 未披露 | 定期报告 | 2020-08-10 |
| 2020-08-11 | 3974.33 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of employee stock options
|
2020-06-30 |
| 2020-05-12 | 3967.36 | 未披露 | 定期报告 | 2020-05-08 |
| 2020-05-12 | 3967.75 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Conversion of redeemable convertible preferred stock to common stock
Initial public offering, net of issuance costs of $11.8 million
Common stock conversion
Exercise of employee stock options
Exercise of stock warrants
|
2020-03-31 |
| 2020-03-19 | 3967.50 | 未披露 | 定期报告 | 2020-02-28 |
| 2020-02-07 | 3967.29 | 未披露 |
更多>>
1.Shares of common stock offered by us 8,350,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 31,322,912 shares of our common stock outstanding as of September 30, 2019
|
2020-02-06 |
| 2020-03-19 | 1065.70 | 1918.10 |
更多>>
from December 31, 2018 to December 31, 2019
Exercise of vested employee stock options
Series D funding
|
2019-12-31 |
From June 30, 2021 to September 30, 2021
Issuance of Common Stock pursuant to the 2020 Equity Plan
From March 31, 2021 to June 30, 2021
Exercise of employee stock options
Issuance of Common Stock pursuant to the 2020 Equity Plan
From December 31, 2020 to March 31, 2021
Exercise of employee stock options
Issuance of Common Stock pursuant to the 2020 Equity Plan
From December 31, 2019 to December 31, 2020
Conversion of redeemable convertible preferred stock to common stock
Initial public offering, net of issuance costs of $11.8 million
Common stock conversion
Exercise of vested employee stock options
Exercise of stock warrants
Issuance of Common Stock pursuant to the 2020 Equity Plan
from June 30, 2020 to September 30, 2020
Exercise of employee stock options
From March 31, 2020 to June 30, 2020
Exercise of employee stock options
From December 31, 2019 to March 31, 2020
Conversion of redeemable convertible preferred stock to common stock
Initial public offering, net of issuance costs of $11.8 million
Common stock conversion
Exercise of employee stock options
Exercise of stock warrants
1.Shares of common stock offered by us 8,350,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 31,322,912 shares of our common stock outstanding as of September 30, 2019
from December 31, 2018 to December 31, 2019
Exercise of vested employee stock options
Series D funding